Asthma inhaler wins, RSV vaccine loses

4 minute read


A new triple therapy inhaler has won PBS backing, while the committee delivered mixed decisions on RSV prevention for infants and older Australians.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×